Evidence map›Paper›PMID 20164270›Full record

ArticleJournal of clinical microbiology2010

Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.

Julie Cremniter, Asma Slassi, Jean-Charles Quincampoix, Valérie Sivadon-Tardy, Thomas Bauer, Raphaël Porcher, Alain Lortat-Jacob, Philippe Piriou, Thierry Judet, Jean-Louis Herrmann and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Probabilistic chemotherapy in knee and hip replacement infection: the place of linezolid.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Observational
  8. Article
  9. Article
  10. Article
  11. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2011
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Julie CremniterEA3647, Université de Versailles Saint-Quentin-en-Yvelines, Garches.
Asma Slassi
Jean-Charles Quincampoix
Valérie Sivadon-Tardy
Thomas Bauer
Raphaël Porcher
Alain Lortat-Jacob
Philippe Piriou
Thierry Judet
Jean-Louis Herrmann
Jean-Louis Gaillard
Martin Rottman
Université de Versailles Saint-Quentin-en-Yvelines · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Ambroise-Paré · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied 315 coagulase-negative Staphylococcus strains recovered prospectively during 240 surgical procedures (206 subjects) from proven or suspected device-associated bone and joint infections. Sixteen strains (5.1%) had decreased susceptibility to glycopeptides: 15 (12 S. epidermidis strains, 2 S. capitis strains, and 1 S. haemolyticus strain) to teicoplanin alone (MIC of 16 mg/liter, n = 9; MIC of 32 mg/liter, n = 6) and one (S. epidermidis) to both teicoplanin and vancomycin (MIC, 16 and 8 mg/liter, respectively). Decreased susceptibility to teicoplanin was more prevalent in "infecting" strains (i.e., strains recovered from >/=2 distinct intraoperative samples) than in "contaminants" (i.e., strains not fulfilling this criterion) (8.1% [12/149] versus 2.4% [4/166], respectively [P = 0.022]). One hundred percent (13/13) of S. epidermidis strains with decreased susceptibility to teicoplanin were resistant to methicillin (versus 112/173 [64.7%] for S. epidermidis strains susceptible to teicoplanin; P = 0.021).

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsCoagulaseFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedProsthesis-Related InfectionsStaphylococcal InfectionsStaphylococcusTeicoplaninVancomycinAnti-Bacterial AgentsCoagulaseTeicoplaninVancomycin

Identifiers

PMID20164270
PMCPMC2849595
OpenAlexW2152990965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.